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The effect of L-ornithine on several types of  im- 
mune reactions  was  analyzed.  L-ornithine  was 
found to suppress  the  activation of cytotoxic T lym- 
phocytes (CTL) in  vivo  and  in  vitro.  This  suppressive 
effect was not observed with the structural ana- 
logues D-ornithine, L-lysine, or putrescine or with 
the  amino  acids  L-histidine or L-alanine.  The con- 
centration of 9 x M L-ornithine  was  found to 
mediate  a  practically  complete  suppression of the 
cytotoxic  response  in vitro if applied on day 0 or 
day 1 of the  culture, but a comparably  weak sup- 
pression if  applied on day 3. The same  concentra- 
tion of  L-ornithine  had no effect on the  production 
of the  lymphokines  interleukin  2 (IL 2) and  7-inter- 
feron  (IFN-7).  This  concentration of ornithine had 
also no substantial  effect on several  types of prolif- 
erative  responses,  including  the  allogeneic  mixed 
lymphocyte  reaction,  the  concanavalin  A-activated 
IL P-dependent  proliferation of thymocytes, and IL 
2-dependent  proliferation of the T cell  clone W-2. 
These observations suggest that L-ornithine in- 
hibits  selectively  the  differentiation of CTL effector 
cells. By the  criteria tested, the  immunosuppressive 
effect of L-ornithine is more selective than  that of 
cyclosporine A, which  was  previously  found to sup- 
press  not  only  the  activation of cytotoxic  activity 
but also proliferative  responses  and  the  production 
of the  lymphokines IL 2 and IFN-7. 
Activated macrophages were shown to contain in- 
creased arginase-activity (1, 2) and to release arginase 
into the extracellular  space (3-5). Arginase converts L- 
arginine  into  urea nd  the  amino acid L-ornithine, which 
serves as  a key precursor  for the polyamine biosynthesis. 
Increased cellular levels of the polyamines spermidine 
and spermine are reportedly required for optimal DNA- 
synthesis in concanavalin A-activated lymphocytes (6) 
(as well as  in  other  types of proliferating cells and  tissue 
(reviewed in References 7, 8)). Ornithine decarboxylase 
activity. the key enzyme in polyamine biosynthesis,  in- 
creases dramatically  within a few hours  after mitogenic 
or  antigenic  stimulation of lymphocytes (9- 1 1). 
Taken  together, these  observations suggested the pos- 
sibility that  the available  concentration of ornithine may 
have a strong influence on the activation process and 
that  the release of arginase by activated macrophages 
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and  the resulting  increase of the L-ornithine concentra- 
tion  in the extracellular  space may serve as a physiologic 
regulatory signal from activated  macrophages  to respond- 
ing lymphocytes. 
We have  therefore  analyzed the effect of L-ornithine on 
several  T cell functions. Our experiments  demonstrate  a 
selective immunosuppressive effect of L-ornithine on the 
early induction of cytotoxic T lymphocyte (CTL)' re- 
sponses. At comparable concentrations, ornithine was 
found  to  have  no effect on  several  types of proliferative 
T cell responses and on the production of the lympho- 
kines  interleukin  2 (IL 2) and y-interferon (IFN-y). The 
immune  suppressive effect of L-ornithine is in this re- 
spect more selective than  that of cyclosporine A, which 
is widely used for  immunosuppressive  therapy  in organ 
transplantation. Cyclosporine A inhibits not only the 
activation of  CTL but  also  inhibits the production of the 
lymphokines IFN-7 (1 2)  and IL 2 (13-1 7). As  a conse- 
quence, cyclosporine A inhibits not only the development 
of the cytotoxic effector  function but also the proliferative 
response  (18-20) of the T cell system. Recently, cyclo- 
sporine A was also found to inhibit the induction of 
ornithine decarboxylase activity (1 1). 
MATERIALS AND METHODS 
Animals. Mice were  purchased from Bomholtgard, Ry, Denmark. 
Eight- to 12-wk-old mice were used  in  most of the experiments. 
Activation  ofcytotoxic  responses in vivo. Mice were treated with 
3 mgcyclophosphamide (Endoxan, Asta, Brackwede. West Germany) 
in 0.15 ml saline i.p. 2 days before immunization (21-23). The 
immunization against trinitrophenylated syngeneic cells was per- 
formed by painting  the mice with 6 X 0.01 ml 20% trinitrochloro- 
benzene (TNCB) in acetone  on  the four footpads and two abdominal 
sites  (22,  23). Immunization against allogeneic cells was performed 
by distributing 5 x lo7 irradiated (1500 rad) allogeneic spleen  cells 
equally into the four footpads in a total volume of 0.2 ml. The 
indicated amounts of L-ornithine were also injected into  the  four 
footpads at  the time of immunization. Five days  after immunization, 
the mice were  sacrificed and  the pooled inguinal and axillary lymph 
nodes  were  directly  tested in a 4-hr 5'Cr-release assay for cytotoxic 
activity  on concanavalin A-activated lymphoblasts a s  target  cells. 
Activation  ofcytotoxic  responses in macrocultures. Twenty mil- 
lion responder  cells  (usually C3H spleen cells)  were incubated with 
1 X lo6 irradiated (1500  rad) allogeneic or trinitrophenylated syn- 
geneic stimulator cells in a total volume of 4.5 ml culture medium 
(RPMI 1640. GIBCO medium supplemented with 10 mM L-glutamine 
[GIBCO]. streptomycin/penicillin (GIBCO, 100 U/ml], 0.5% HEPES 
ethanol) for 5 days at  37°C in 5% COz. The responder and  stimulator 
[GIBCO]. 10% fetal calf serum [GIBCO]. and 3 x M 2-mercapto- 
cells were spleen cells. The cultures were tested after 5 days for 
cytotoxic activity against concanavalin A-activated allogeneic or 
trinitrophenylated syngeneic  spleen cell blasts in a 4-hr "Cr-release 
assay as described (24,  25). 
Activation of cytotoxic  responses  in the presence of IL 2-con- 
taining cell supernatants in microcultures. C3H spleen cells (5 x 
' Abbreviations  used  in this paper: CTL,  cytotoxic T lymphocyte: IFN. 
interferon; IL 2. interleukin 2: PMA. phorbol myristic acetate: TNCB. 
trinitrochlorobenzene. 
3379 
3380 INHIBITION OF CYTOTOXIC  RESPONSES BY L-ORNITHINE 
lo4) were incubated as responder  cells  with 3 X lo5 trinitrophen- 
ylated and  irradiated (1 500 rad) C3H spleen  cells  and  the  indicated 
amounts of IL 2-containing EL-4 supernatant  in 0.2-1111 microcul- 
canavalin  A-activated C3H spleen  cells  blasts  was  tested  after 5 days 
tures.  The  cytotoxic  activity  against 2 X lo4 trinitrophenylated  con- 
in a 4-hr  ”Cr-release  assay as described  (24). 
Assay  of DNA synthesis.  The DNA synthesis in microcultures 
was  assayed by adding 1 pCi of [3H]thymidine per 0.2 ml culture. 
The microcultures were usually incubated for another 8 hr.  then 
were harvested with a Scatron-cell-harvester [Flow Laboratories), 
and  the  filters  were  counted  in a liquid  scintillation  counter.  Each 
point  was  assayed  in  quadruplicate if not  indicated  otherwise. 
Assay for  IL 2 activity. The 1L 2 titers  were  determined  with  the 
1L 2-dependent  W-2 T cell line as described  (26). 
microtiter assay  with  L929  cells  (0.2 ml of medium [RPMl 1640 + 
Assay for  IFN activity. IFN titrations  were  performed by using a 
5% FCS] per well) and  vesicular  stomatitis  virus  [Indiana  strain) as 
capable of conferring  protection  to 50% of the cells.  One  microtiter 
challenge  virus.  One  unit  corresponds  to  the  minimal  amount f  IFN 
unit/0.2  ml  corresponds  to 2 NIH reference  units/ml. All titers  are 
expressed  in  laboratory  units. 
The  preparation O J K  2-contalning  supernatants. Supernatants 
were  obtained  from a n  IL 2-producing EL-4 thymoma  subline  after 
induction with phorbol myristic acetate (PMA) as described (27).  
Briefly, lo6 EL-4 cells/ml  were  incubated  together  with 10 ng PMA/ 
ml (SIGMA) for 48 hr. The superantant was collected and stored 
frozen a t  -20°C. 
RESULTS 
The  suppressive  effects of L-ornithine on cytotoxic 
responses. Ornithine  was  found to exert a strong  sup- 
pressive effect on cytotoxic responses  in vivo and in vitro 
against  haptenated  syngeneic  or allogeneic target cells 
(Fig. 1). The cytotoxic response of cyclophosphamide- 
treated C3H mice against allogeneic C57BL/6 cells in vivo 
was always a priori relatively weak but was also sup- 
pressed by the injection of L-ornithine (data  not  shown). 
The  dose-response  curves for the effects of ornithine in 
vivo and in vitro are  shown  in Figure 2 and Figure 3, 
respectively. Figure 3 shows  also that  the suppression is 
more pronounced when  ornithine is added in  the early 
phase, Le., on day 0 or day 1, rather  than on day 3 of the 
cytotoxic response. The suppressive effect is not ob- 
served with the structural analogues D-ornithine, L-ly- 
Th e suppresswe eftect 01 omlhlne on cylotox~c responses tn vwo and m vltro 
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Figure 1 .  The suppressive  effect of ornithine on cytotoxic responses 
in vivo and in vitro. Effect in vivo (left  panel]: C3H mice received 3 mg 
cyclophosphamide in 0.15 ml Bss i.p. and were immunized 2 days later 
with 6 x 0.01 ml of a 20% solution of TNCB in acetone  painted  on the 
skin  at two abdominal sites  and on the four  footpads. Immediately before 
immunization. 4 X 0.05 ml  BSS containing  the indicated concentrations 
of ornithine were injected into  the  four footpads. The mice were sacrificed 
5 days later. and  the cytotoxic actlvity of the pooled inguinal and axillary 
lymph node cells against ”Cr-labeled trinitrophenylated C3H target  cells 
was  tested at  the indicated attacker  to target cell ratios. Effect in vitro 
[middle and right panels): C3H spleen cells (2 X lo’) were incubated 
panel) or 1 x 10‘ irradiated C57BL/6 spleen  cells (right  panel) and with 
with 1 x 10’ irradiated and trinitrophenylated C3H spleen  cells (middle 
days.  The cytotoxic actlvity against  the corresponding  target  cells was 
the indicated  final concentrations of ornithine in 4.5 ml cultures for 5 
tested after 5 days. 
Inhibition of the cytotoxic response 
by ornithine i m o  
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sponse in vivo. C3H mice were  treated with cyclophosphamide and im- 
Figure2. Effect of graded doses of L-ornithine on the cytotoxic re- 
munized with TNCB as described in the legend to Figure 1. immediately 
before immunization, 4 x 0.05 ml Bss with graded concentrations of 
ornithine were injected into  the four footpads. After 5 days,  the cytotoxic 
activity of the pooled and inguinal axillary lymph node cells against 
trinitrophenylated C3H target  cells was tested at  attacker to  target cell 
activity at  attacker to target cell ratio 50: 1. [The control response  without 
ratios of 50:l. 1O:l. and 2:l. The figure shows the relative cytotoxic 
ornithine showed 32% specific 51Cr release.) 
sine,  or  putrescine  or  with  the  amino  acids L-histidine or 
L-alanine (Table I). 
In order  to  distinguish  whether  ornithine  inhibits the 
activation of CTL precursor cells directly or only indi- 
rectly through the inhibition of helper T cells, experi- 
ments were performed in IL 2-containing microcultures. 
The  results of these experiments (Fig. 4) revealed that 
ornithine  also  exerts  a  strong  suppressive effect on cy- 
totoxic responses  in IL 2-containing  cultures.  The sup- 
pressive effect again  was more pronounced if ornithine 
was added on day 0 or day 1 rather  than on day 3 of the 
culture. 
The effect of L-ornithine on  lymphokine  production. 
The concentration of 9 X ornithine, which has been 
found  to suppress cytotoxic responses completely, had no 
substantial effect on the production of IL 2  or IFN-7 (Fig. 
5). Graded concentrations of ornithine were added to 
cultures of concanavalin A-activated C3H spleen cells 
( lo7 cells + 5 pg concanavalin A/ml). The  resulting su- 
pernatants were harvested 24 hr later  and were tested 
for IL 2 and IFN activity. The  results (Fig. 5) show that 
the production of both lymphokine activities was not 
markedly affected by the addition of ornithine.  Similar 
results were obtained  with  respect to the IL 2 and IFN 
titers  after 48 hr of culture  and also with respect to the 
IL 2 titers in ornithine  containing  cultures of PMA acti- 
vated EL-4 thymoma cells (data  not  shown). C3H spleen 
cell cultures with 1 pg/ml concanavalin A and allogeneic 
mixed lymphocyte cultures  containing 10’ nonirradiated 
C3H spleen  cells  plus lo7 nonirradiated C57BL/6 spleen 
cells were also set  up with graded concentrations of or- 
nithine. However, their  supernatants showed no IL 2  or 
IFN activity irrespective of the  amount of ornithine added 
(data not shown). Control solutions containing graded 
amounts of ornithine  in  culture medium also showed no 
lymphokine  activities in the two assay  systems  (data not 
shown). These control experiments showed that orni- 
thine by itself has no IL 2 or IFN activity and does not 
induce lymphokine production in lymphocyte cultures. 
Also. ornithine  had no enhancing or  inhibitory effect on 
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Effect of graded concentrations of ornithine on cytotoxic 
responses in vitro 
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Figure 3. Effect of graded  doses of ornithine on cytotoxic response  in 
vitro. C3H spleen  cells (2 x lo7) were  incubated  with  1 x 10' irradiated 
and  trinitrophenylated C3H spleen  cells  (upper  panel) or 1 x lo6 irradi- 
ated C57BL/6 spleen  cells  (lower panel)  in  4.5 ml cultures  for 5 days. At 
day 0. day 1. or day 3, the  cultures  were  supplemented  with  0.2 ml culture 
medium  containing  graded  concentrations of L-ornithine.  The  abscissa 
indicates  the  final  concentration of ornithine  in  the  culture.  The cytotoxic 
activity  against  the  corresponding  target  cells  was  tested  after 5 days at  
attacker  to  target cell ratios of 25:  1,  5:  1  and  1 :1.  The  data  indicate  the 
relative cytotoxic activity at  the  attacker to  target cell ratio 25:l.  (The 
control  responses  without  ornithine  showed  54%  [upper  panel]  and  50% 
"Cr-release  [lower panel].] 
TABLE I 
Effect ofdwerent  amino  acids  and  putrescine  on  the  activation 
of CTL" 
Added 
Component Expt. 
Stimulator and Target 
TNP-C3H C57BL/6 
I none 54.9 32.0 16.3 33.5 17.7 4.8 
I.-ornithine 7.9 3.7 3.2 1.8 -1.7 -0.2 
!<-lysine 60.7 39.9 21.5 41.7 19.1 9.0 
L-histidine 48.5 27.8 11.1 24.5 11.4 5.1 
L-alanine 40.5 25.3 9.8 19.2 5.3 6.7 
putrescine 44.2 24.8 9.6 30.2 11.9 7.2 
I1 none 63.9 34.1 13.8 67.8 40.6 12.3 
L-ornithine 17.6 2.9 -1.8 17.5 2.5 1.5 
0-ornithine 64.3 38.4 13.7 64.2 43.6 15.0 
trinitrophenylated C3H spleen cells or C57BL/6 spleen cells in 5-ml 
"C3H spleen cells (2 x IO7) were incubated with 5 x 10' irradiated 
cultures  containing,  in  addition to the  standard  medium.  components of 
the  indicated  amino  acids or putrescine at  a  concentration of 1 x lo-' 
mol/liter.  The  data  indicate  the cytotoxic activity  (percent of 51Cr release] 
against homologous target cells after 5 days at attacker to target cell 
ratiosof25:1.5:1.and  1:l.  
the two assay systems. 
The  effect of ornithine  on  proliferative  responses. A 
final  set of experiments  was designed to  test  the  effects 
Effect of ornithine  on  cytotoxic  responses  in  microcultures 
supplemented  with IL - 2 containing EL - 4 supernatant 
~-0rnlthine added 
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Figure 4. Effect of ornithine on cytotoxic responses on microcultures 
supplemented  with IL 2-containing EL-4 supernatant. C3H spleen cells 
ylated C3H spleen  cells  and  0.015 ml EL-4 supernatant  (2 U of IL 2).  The 
(5 X 10') were  incubated  with 3 X lo5 irradiated  (1500  rad)  trinitrophen- 
cultures  were  supplemented  on  day 0. day 1, or day 3 with  0.02 ml culture 
medium  containing  graded  concentrations of L-ornithine. The  abscissa 
indicates  the  final  concentration of ornithine  in  the  cultures.  The cyto- 
toxic activity against TNP-haptenated syngeneic target cells (2 x IO4/ 
well) was  tested at  day 5. (The  control  response showed 54% 6'Cr-release.) 
Effect of L-ornithine  on  the  production of lntedeukin 2 
and y - Interferon 
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Figure 5. Effect of L-ornithine on the  production of IL 2  and IFN-y. 
C3H spleen cells (1 x 107/ml) were incubated  with  concanavalin A (5 &/ 
ml) and  the indicated  final  concentrations of L-ornithine for 24  hr in  4- 
ml macrocultures. The resulting supernatants were then isolated by 
centrifugation and tested  for IL 2  and IFN activity as  described in Mate- 
rials  and Methods. IL 2 production by PMA-activated EL-4 thymoma 
cells was  also  tested  and  was  also  not  suppressed by th se  concentrations 
of L-ornithine (data  not  shown).  The  slight  suppression of the IFN titer  at 
3 x M L-ornithine is not a reproducible  and  meaningful  effect as  
judged from three  independent  experiments. 
of ornithine on three types of proliferative T cell re- 
sponses.  First, mixed lymphocyte cultures  containing 3 
X lo5 C3H spleen cells and 3 X lo5 irradiated (1500 rad) 
C57BL/6 spleen cells as stimulator cells with or without 
0.15 ml EL-4 supernatant  (2 U IL 2/culture) were incu- 
bated with graded doses of L-ornithine. The  results (Fig. 
6) revealed that ornithine had no effect on the DNA- 
synthesis response (13H]thymidine incorporation) at  any 
of the concentrations tested (Fig. 6). Second. C3H thy- 
mocytes (1  x lo5) were incubated with IL 2 (2 U/culture) 
and with graded concentrations of concanavalin A and 
L-ornithine and  in 0.2-ml microcultures.  The  results (Fig. 
7) showed again that  ornithine  had no effect on the DNA 
synthesis of the responding lymphocytes. Third, 1 O4 cells 
of the W-2 T cell clone were incubated with IL 2 (0.5 U/ 
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Figure6 .  Effect of L-ornithine on the proliferative response in the 
allogeneic mixed lymphocyte culture. C3H spleen cells (3 X IO5) were 
or without 0.015 ml  EL-4 supernatant in 0 . 2 4  microcultures. The DNA- 
incubated with 3 X IO5 irradiated (1500 rad]  C57BL/6 spleen cells with 
synthesis  was determined 3 days and 5 days later as described in Mate- 
rials and Methods. 
I 
Effect of ornithine  on  the  mitogenic  stimulation of thymocytes 
by Concanavalin A 
Con A/well. 
*-e none 
m-• 0.2 vg 
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cytes by concanavalin A. C3H thymus cells ( I  X 10') were incubated with 
Figure 7. Effect of ornithine on the mitogenic stimulation of thymo- 
the indicated amounts of concanavalin A and with 2 U of IL 2 and the 
synthesis was tested 3 days later as described in Materials and Methods. 
indicated concentrations of L-ornithine in 0.2-ml microcultures. The DNA 
culture]  and graded doses of L-ornithine in 0.2-ml micro- 
cultures for 20 hr at 37°C. The W-2 cells were then 
assayed  for DNA synthesis as described for the IL 2 assay 
(Materials and Methods). Again, ornithine  had  no  effect 
on the DNA synthesis of this T cell clone (Fig. 8). 
DISCUSSION 
Our  experiments  demonstrated  a  strong  immunosup- 
pressive effect of L-ornithine on the activation of  CTL in 
vivo and in vitro. On the  other  hand,  ornithine  in  similar 
concentrations  had no effect  on the production of IL 2 or 
IFN--/ by concanavalin A-activated C3H spleen cells or 
PMA-activated  EL-4 thymoma cells. I t  had  also  no  effect 
on  several  types of proliferative responses,  including  the 
allogeneic mixed lymphocyte reaction, the IL 2-dependent 
Effect of ornithine  on  the IL-2 dependent DNA synthesis 
of the W - 2  T cell  clone 
X I 
6 40 
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Figure 8. Effect of  L-ornithine on the IL 2-dependent DNA synthesis 
of the W-2 T cell clone. Cells of the W-2 T cell clone [ lo4) were incubated 
with IL 2 (0.5 U) and graded concentrations of L-ornithine in 0.2-ml 
microcultures for 20 hr. The cultures were then assayed for DNA synthe- 
sis as described for the IL 2  assay  [see Materials and Methods). 
proliferative response of concanavalin A-activated thy- 
mocytes, and  the IL 2-dependent proliferation of the W- 
2 T cell clone. These  observations indicated that L-orni- 
thine  at  the  concentrations tested  had  no  general toxic 
effect  on  the responding cell populations  but exerted a 
selective immunosuppressive effect on the activation of 
CTL precursor cells. This conclusion was also  supported 
by the  fact  that  the cytotoxic responses were strongly 
suppressed  when  ornithine  was added during the  first 2 
days of the response,  but  they were much  less  affected if 
ornithine  was added on day 3. Whether  ornithine at  these 
concentrations selectively suppressed  the  maturation of 
CTL activity or whether it suppressed  the proliferation of 
CTL precursor cells without  inhibiting the proliferation 
of other  T cell subsets  cannot be distinguished  with the 
available  experimental  information. It should be empha- 
sized that  the responder cells from in vivo and  the ma- 
croculture  experiments (Figs. 2 and 3) were washed be- 
fore  they were mixed with the target cells. This point, 
and  the  fact  that cytotoxic responses were strongly in- 
hibited when L-ornithine was added in the early and not 
in the late phase of the response, argued against the 
possibility that L-ornithine exerted its effect on the target 
cell rather  than on the CTL precursor. 
The mechanism of this suppressive effect is unknown. 
Its structural specificity, however, is remarkable:  a sim- 
ilar effect is not observed with the  structural analogues 
D-ornithine, L-lysine, or putrescine or with some other 
amino  acids. It is well established that antigenically or 
mitogenically activated lymphocytes express increased 
intracellular levels of ornithine decarboxylase (9-1 11, a 
key enzyme for the biosynthesis of polyamines, which 
are required for cell growth and differentiation. It there- 
fore  seems possible that  the  external addition of L-orni- 
thine may lead to an excess of polyamines or may induce 
a feedback suppression of the  ornithine  generating  en- 
zymes (i.e.,  arginase),  and  thereby  generate an ornithine 
deficiency in  the  later  phase of the response. 
Activated macrophages  express high arginase activity 
(3-5) and  are thereby expected to  increase  the  concentra- 
tion of L-ornithine in the extracellular space. Cultured 
macrophages  accumulate L-ornithine in  the  supernatant 
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(H. Kriegbaum and W. Droge, unpublished  observation). 
It is conceivable that a concentration of M L-orni- 
thine may also occur  in vivo in  the immediate  uicinity 
of the ornithine-producing cells. The selective inhibition 
of the development of CTL activity by L-ornithine may 
therefore be part of a physiologic regulatory signal. Un- 
fortunately, it is difficult  to test  the L-ornithine concen- 
tration in the immediate vicinity of individual cells in 
vivo, The fact that  the late phase of the cytotoxic re- 
sponses is less sensitive against L-ornithine than the 
early  induction may also provide an explanation  for the 
reported observation (28-30) that activated lymphocyte 
populations can prevent nonactivated CTL precursor 
cells from being recruited  into the activated pool without 
inhibiting the previously induced CTL precursor cells to 
mature  into  functional CTL. This selective  inhibition of 
the nonactivated  precursor cells may well be mediated by 
L-ornithine-producing cells  in the activated cell popula- 
tion. On the  other  hand,  in view of the relatively high 
effective concentration of L-ornithine, one should also 
consider the possibility that L-ornithine may only mimic 
a natural analogue  with  a  similar  function. 
Irrespective of whether a local concentration of 1 0-2 M 
L-ornithine occurs in physiologic situations, L-ornithine 
may turn out  to be a useful  immune  response modifier 
because of its relatively selective regulatory effects. A 
comparison of L-ornithine with the  immune  suppressive 
agent cyclosporine A revealed remarkable  differences. In 
contrast to L-ornithine, cyclosporine A was shown to 
inhibit not only the induction of cytotoxic responses  but 
also proliferative responses  against mitogens and alloan- 
tigens (18-20) and  the production of the lymphokines 1L 
2 (1 3-1 7) and IFN-7 (12). In  view of its more selective 
immunosuppressive  effect, it seems possible that orni- 
thine will find  a field of application  complementary to 
cyclosporine A as an immunosuppressive agent in hu- 
man  therapy. 
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